Longevity, Aging Drugs: Treatments Could Take Years. Investors Are Pouring Billions Into Them.

Biotech start-ups are trying to use that knowledge to keep people healthier as they grow older with the aim of eventually extending the human life span

Related Keywords

Switzerland ,Swiss ,Alex Colville ,Jim Mellon ,Jeff Bezos ,Neal Templin ,Kristen Fortney ,Sergey Jakimov ,Eli Lilly ,Phil Newman ,Eric Verdin ,Amol Sarva ,Longevity Technology ,Buck Institute For Research On ,Longevity Technology Newman ,Altos Labs ,Editor In Chief Phil Newman ,Incarda Therapeutics ,Bioage Labs ,Life Extension Ventures ,Extension Ventures ,Curve Biosciences ,Silicon Valley ,Buck Institute ,Article Normal ,Pharmaceuticals ,Cancer Drugs ,Scientific Research Services ,Healthcare Life Sciences ,Business Consumer Services ,Specialized Drugs Medications ,Medical Research Services ,Drug Discovery Development ,Healthcare Support Services ,Diagnostic Medical Research Services ,Biology ,Biotechnology ,Political General News ,Physical Mental Fitness ,Health ,Living Lifestyle ,Sciences Humanities ,Weight Management ,Synd ,Biotech And Pharma ,Financial Planning ,Retirement ,Amazon Com ,Amzn ,Rally ,Political ,General News ,Physical ,Mental Fitness ,Living ,Lifestyle ,Sciences ,Humanities ,Healthcare ,Life Sciences ,Business ,Consumer Services ,Specialized Drugs ,Medications ,Drug Discovery ,Development ,Diagnostic ,